Works matching DE "CLOFIBRATE"

Results: 108

Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report.

Published in:

European Journal of Clinical Pharmacology, 2009, v. 65, n. 12, p. 1169, doi. 10.1007/s00228-009-0723-7

By:

Jianyong Wu;
Yan Song;
Heng Li;
Jianghua Chen

Publication type:

Article

Effects of maternal feeding of clofibrate on hepatic fatty acid metabolism in suckling piglet.

Published in:

Journal of Animal Science & Biotechnology, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s40104-024-01104-6

By:

Zhao, Jinan;
Pike, Brandon;
Wang, Feng;
Yang, Lin;
Meisner, Paige;
Huang, Yanling;
Odle, Jack;
Lin, Xi

Publication type:

Article

Comparison of the Effects of Clofibrate and Silafibrate on Sperm Parameters Quality and Sex Hormones in Male Rats.

Published in:

Urology Journal, 2018, v. 15, n. 2, p. 38

By:

Delashoub, Masoud;
Ziaee, Mojtaba;
Khorrami, Arash;
Banan-Khojasteh, Seyed Mehdi

Publication type:

Article

Intrahepatic Cholestasis Following the Use of Atromid-S.

Published in:

American Journal of Gastroenterology (Springer Nature), 1976, v. 66, n. 1, p. 69

By:

Valdes, Mariano;
Jacobs, Walter H.

Publication type:

Article

CLINICAL AND BIOCHEMICAL OBSERVATIONS ON THE USE OF LARGE DOSES OF TESTOSTERONE PROPIONATE IN ACUTE AND CHRONIC LIVER DISEASE.

Published in:

American Journal of Gastroenterology (Springer Nature), 1954, v. 21, n. 2, p. 89

By:

Morgan Jr., Frank M.;
Wharton, George K.;
Starr, Paul;
Commons, Robert R.

Publication type:

Article

Estrogen and androgen receptor status in hepatocellular hypertrophy induced by phenobarbital, clofibrate, and piperonyl butoxide in F344 rats.

Published in:

Journal of Toxicological Sciences, 2012, v. 37, n. 2, p. 281, doi. 10.2131/jts.37.281

By:

Nariaki Fujimoto;
Kaoru Inoue;
Midori Yoshida;
Akiyoshi Nishikawa;
Shogo Ozawa;
Toshie Gamou;
Kiyomitsu Nemoto;
Masakuni Degawa

Publication type:

Article

Role of cytosolic liver fatty acid binding protein in hepatocellular oxidative stress: effect of dexamethasone and clofibrate treatment.

Published in:

Molecular & Cellular Biochemistry, 2007, v. 295, n. 1, p. 27, doi. 10.1007/s11010-006-9268-6

By:

G. Rajaraman;
G. Wang;
J. Yan;
P. Jiang;
Y. Gong

Publication type:

Article

Clofibrate Relaxes the Longitudinal Smooth Muscle of the Mouse Distal Colon through Calcium-Mediated Desensitisation of Contractile Machinery.

Published in:

Pharmacology, 2011, v. 88, n. 1/2, p. 65, doi. 10.1159/000329418

By:

Azuma, Yasu-Taka;
Nishiyama, Kazuhiro;
Morioka, Ai;
Nakajima, Hidemitsu;
Takeuchi, Tadayoshi

Publication type:

Article

Clofibrate in the Treatment of the Non-hemolytic Hyperbilirubinemia in Preterm Neonates in Western Iran.

Published in:

Iranian Journal of Neonatology, 2021, v. 12, n. 3, p. 48, doi. 10.22038/ijn.2021.52072.1927

By:

Eghbalian, Fatemeh;
Jenabi, Ensiyeh;
Hatami, Elham;
Basiri, Behnaz;
Derakhshandeh, Katayoun;
Pezeshki, Nasrollah;
Khanlarzadeh, Elham

Publication type:

Article

Evaluation of the Effect of Oral Clofibrate Intake on Neonatal Total Serum Bilirubin: a Randomized Clinical Trial.

Published in:

Iranian Journal of Neonatology, 2016, v. 7, n. 3, p. 5

By:

NouriShadkam, Mahmood;
Mohammadi, Mohmmad Javad;
Nasiriani, Khadijeh

Publication type:

Article

Effect of clofibrate on serum triglyceride and cholesterol after intravenous lipid in very low birth weight neonates.

Published in:

Iranian Journal of Neonatology, 2013, v. 4, n. 3, p. 20

By:

Mohammadzadeh, A.;
Farhat, A. S.;
Esmaeli, H.;
Amiri, R.

Publication type:

Article

Comparison of the efficacy of Clofibrate with Phenobarbital in decreasing neonatal hyperbilirubinemia.

Published in:

Iranian Journal of Neonatology, 2013, v. 4, n. 3, p. 13

By:

Ahadi, A.;
Mirzarahimi, M.;
Ahmadabadi, F.;
Tavasoli, A.;
Parvaneh, N.

Publication type:

Article

FLOW CYTOMETRIC EVALUATION OF SYNERGISTIC PRO-APOPTOTIC EFFECTS OF STATINS AND CLOFIBRATES IN IM-9 HUMAN LYMPHOBLASTS.

Published in:

Clinical & Experimental Pharmacology & Physiology, 2007, v. 34, n. 9, p. 876, doi. 10.1111/j.1440-1681.2007.04677.x

By:

Tomiyama, Naoki;
Yasuda, Noriko;
Iwano, Chihiro;
Matzno, Sumio;
Matsuyama, Kenji

Publication type:

Article

LETTERS AND COMMENTS.

Published in:

1968

By:

Ahrens Jr., E.H.;
Emmer, Michael;
DeVita, Vincent T.;
Jones, Thomas C.;
Cardamone, Joseph M.;
MacKay, Donald N.;
Kaye, Donald;
Goodwin, Norma J.;
Friedman, Eli A.;
Lawrence, John H.;
Klein, Herman

Publication type:

Letter

Caspase 2 Activation and ER Stress Drive Rapid Jurkat Cell Apoptosis by Clofibrate.

Published in:

PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0045327

By:

Penna, Fabio;
Pin, Fabrizio;
Costamagna, Domiziana;
Reffo, Patrizia;
Baccino, Francesco Maria;
Bonelli, Gabriella;
Costelli, Paola;
Tjwa, Marc

Publication type:

Article

The Effect of Purgative Manna and Clofibrate on Neonatal Unconjugated Hyperbilirubinemia.

Published in:

Acta Medica Iranica, 2019, v. 57, n. 6, p. 368

By:

Mahyar, Abolfazl;
Mehrpisheh, Shahrokh;
Khajeh, Bahman;
Ayazi, Parviz;
Oveisi, Sonia;
Mahyar, Shifteh;
Esmaeili, Shiva

Publication type:

Article

Nuclear factor PPAR-α induction in the heart plays a pivotal role in determining the final outcome of doxorubicin-induced cardiotoxicity.

Published in:

FASEB Journal, 2007, v. 21, n. 6, p. A799, doi. 10.1096/fasebj.21.6.a799-c

By:

Mitra, Mayurranjan S.;
Donthamsetty, Shishikiran;
Latendresse, John R.;
Mehendale, Harihara M.

Publication type:

Article

From Fleming to Endo: The discovery of statins.

Published in:

Global Cardiology Science & Practice, 2021, v. 2021, n. 4, p. 1, doi. 10.21542/gcsp.2021.32

By:

Chester, Adrian

Publication type:

Article

Case Report : The Treatment of Xanthomatosis with Atromid-S.

Published in:

Australasian Journal of Dermatology, 1969, v. 10, n. 2, p. 92, doi. 10.1111/j.1440-0960.1969.tb01175.x

By:

Chermsirivathana, Sunit;
Phisithkul, Songsak

Publication type:

Article

The effect of aging on the repeated-dose liver micronucleus assay.

Published in:

Genes & Environment, 2021, v. 43, n. 1, p. 1, doi. 10.1186/s41021-021-00212-3

By:

Shigano, Miyuki;
Takasawa, Hironao;
Hamada, Shuichi

Publication type:

Article

Alopecia areata treated with DNCB.

Published in:

Clinical & Experimental Dermatology, 1979, v. 4, n. 3, p. 385, doi. 10.1111/j.1365-2230.1979.tb02660.x

By:

Hehir, Maureen E.;
du Vivier, Anthony

Publication type:

Article

Clinical pharmacokinetics of fibric acid derivatives (fibrates).

Published in:

1998

By:

Miller, D.B.;
Spence, J.D.

Publication type:

journal article

Transplacental induction of fatty acid oxidation in term fetal pigs by the peroxisome proliferator-activated receptor alpha agonist clofibrate.

Published in:

Journal of Animal Science & Biotechnology, 2015, v. 6, n. 1, p. 1, doi. 10.1186/s40104-015-0010-7

By:

Xi Lin;
Jacobi, Sheila;
Odle, Jack

Publication type:

Article

Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells.

Published in:

Biochemistry & Cell Biology, 2010, v. 88, n. 6, p. 957, doi. 10.1139/o10-151

By:

Yan, Jing;
Gong, Yuewen;
Wang, Guqi;
Gong, Yu;
Burczynski, Frank J.

Publication type:

Article

Fibrates: What Have We Learned in the Past 40 Years?

Published in:

Pharmacotherapy, 2007, v. 27, n. 3, p. 412, doi. 10.1592/phco.27.3.412

By:

Backes, James M.;
Gibson, Cheryl A.;
Ruisinger, Janelle E.;
Moriarty, Patrick M.

Publication type:

Article

Clofibrate Induces Heme Oxygenase 1 Expression through a PPARα-Independent Mechanism in Human Cancer Cells.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2013, v. 32, n. 5, p. 1255, doi. 10.1159/000354524

By:

Wang, Shuai;
Hannafon, Bethany N.;
Zhou, Jundong;
Ding, Wei-Qun

Publication type:

Article

Clofibrate and dalargin increase luminol-dependent chemiluminescence of mouse blood.

Published in:

Bulletin of Experimental Biology & Medicine, 2007, v. 144, n. 3, p. 317, doi. 10.1007/s10517-007-0321-6

By:

V. Mushtakova;
V. Rogovin

Publication type:

Article

Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet.

Published in:

European Journal of Nutrition, 2008, v. 47, n. 4, p. 192, doi. 10.1007/s00394-008-0713-z

By:

Sugatani, Junko;
Osabe, Makoto;
Wada, Tadashi;
Yamakawa, Kasumi;
Yamazaki, Yasuhiro;
Takahashi, Tadanobu;
Ikari, Akira;
Miwa, Masao

Publication type:

Article

Prenatal PPARα activation by clofibrate increases subcutaneous fat browning in male C57BL/6J mice fed a high-fat diet during adulthood.

Published in:

PLoS ONE, 2017, v. 12, n. 11, p. 1, doi. 10.1371/journal.pone.0187507

By:

Chen, Szu-Han;
Chao, Pei-Min

Publication type:

Article

Genomic Profiling Reveals an Alternate Mechanism for Hepatic Tumor Promotion by Perfluorooctanoic Acid in Rainbow Trout.

Published in:

Environmental Health Perspectives, 2008, v. 116, n. 8, p. 1047, doi. 10.1289/ehp.11190

By:

Tilton, Susan C.;
Orner, Gayle A.;
Benninghoff, Abby D.;
Carpenter, Hillary M.;
Hendricks, Jerry D.;
Pereira, Cliff B.;
Williams, David E.

Publication type:

Article

Safety of fibrates in cholestatic liver diseases.

Published in:

Liver International, 2021, v. 41, n. 6, p. 1335, doi. 10.1111/liv.14871

By:

Carrion, Andres F.;
Lindor, Keith D.;
Levy, Cynthia

Publication type:

Article

Preparation and characterization of a powder containing an oily liquid drug with Eudragit EPO or L100 copolymer.

Published in:

Pharmaceutical Development & Technology, 2016, v. 21, n. 8, p. 1023, doi. 10.3109/10837450.2015.1086370

By:

Fujii, Makiko;
Kawakami, Ayari;
Saito, Asumi;
Tuchiya, Haruna;
Koizumi, Naoya;
Watanabe, Yoshiteru

Publication type:

Article

Clofibrate, a PPAR‐α agonist, abrogates sodium fluoride‐induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba‐1/anti‐calbindin signaling pathways.

Published in:

Environmental Toxicology, 2020, v. 35, n. 2, p. 242, doi. 10.1002/tox.22861

By:

Oyagbemi, Ademola A.;
Adebiyi, Olamide E.;
Adigun, Kabirat O.;
Ogunpolu, Blessing S.;
Falayi, Olufunke O.;
Hassan, Fasilat O.;
Folarin, Oluwabusayo R.;
Adebayo, Adedeji K.;
Adejumobi, Olumuyiwa A.;
Asenuga, Ebunoluwa R.;
Ola‐Davies, Olufunke E.;
Omobowale, Temidayo O.;
Olopade, James O.;
Saba, Adebowale B.;
Adedapo, Adeolu A.;
Nkadimeng, Sanah M.;
McGaw, Lyndy J.;
Oguntibeju, Oluwafemi O.;
Yakubu, Momoh A.

Publication type:

Article

Novel Use of a Lipid-Lowering Fibrate Medication to Prevent Nicotine Reward and Relapse: Preclinical Findings.

Published in:

Neuropsychopharmacology, 2012, v. 37, n. 8, p. 1838, doi. 10.1038/npp.2012.31

By:

Panlilio, Leigh V;
Justinova, Zuzana;
Mascia, Paola;
Pistis, Marco;
Luchicchi, Antonio;
Lecca, Salvatore;
Barnes, Chanel;
Redhi, Godfrey H;
Adair, Jordan;
Heishman, Stephen J;
Yasar, Sevil;
Aliczki, Mano;
Haller, Jozsef;
Goldberg, Steven R

Publication type:

Article

Effects of PPAR-A agonists on in vitro liver fatty acid metabolism in Holstein calves.

Published in:

Journal of Animal Science, 2006, v. 84, p. 265

By:

Litherland, N. B.;
Carlson, D. B.;
Wallace, R. L.;
Drackley, J. K.

Publication type:

Article

Effects of chromium propionate on growth, carcass traits, and pork quality of growing-finishing pigs.

Published in:

Journal of Animal Science, 2005, v. 83, n. 4, p. 858, doi. 10.2527/2005.834858x

By:

Matthews, J. O.;
Guzik, A. C.;
Lemieux, F. M.;
Southern, L. L.;
Bidner, T. D.

Publication type:

Article

Peroxisome Proliferator Activator α Agonist Clofibrate Induces Pexophagy in Coconut Oil-Based High-Fat Diet-Fed Rats.

Published in:

Biology (2079-7737), 2024, v. 13, n. 12, p. 1027, doi. 10.3390/biology13121027

By:

Ohshima, Kanami;
Hara, Emika;
Takimoto, Mio;
Bai, Yidan;
Hirata, Mai;
Zeng, Wen;
Uomoto, Suzuka;
Todoroki, Mai;
Kobayashi, Mio;
Kozono, Takuma;
Kigata, Tetsuhito;
Shibutani, Makoto;
Yoshida, Toshinori

Publication type:

Article

Is hepatic peroxisome proliferator‐activated receptor α essential for the metabolic effects of fibrates?

Published in:

2018

By:

Kamijo, Y.

Publication type:

Editorial

A rational Approach For Synthesis and Characterization of 5-[(5-Phenyl-1H-Tetrazol-1-yl) Methyl]- 3(Substituted Aryl)- 4H-1,2,4-Triazoles.

Published in:

Drug Invention Today, 2010, v. 2, n. 5, p. 240

By:

Khanage, S. G.;
Mohite, P. B.;
Pandhare, R. B.;
Deshmukh, V. K.;
Raju, S. Appala

Publication type:

Article

Effects of Peroxisome Proliferators Gemfibrozil and Clofibrate on Syntheses of Dolichol and Cholesterol in Rat Liver.

Published in:

Journal of Biochemistry, 2003, v. 134, n. 2, p. 197, doi. 10.1093/jb/mvg129

By:

Shiota, Yasuo;
Ikeda, Masatoshi;
Hashimoto, Fumie;
Hayashi, Hidenori

Publication type:

Article

Transcription Profiling Distinguishes Dose-Dependent Effects in the Livers of Rats Treated with Clofibrate.

Published in:

Toxicologic Pathology, 2003, v. 31, n. 4, p. 417, doi. 10.1080/01926230309726

By:

Kramer, Jeffrey A.;
Blomme, Eric A. G.;
Bunch, Roderick T.;
Davila, Julio C.;
Jackson, Carmen J.;
Jones, Patrick F.;
Kolaja, Kyle L.;
Curtiss, Sandra W.

Publication type:

Article

Appendix II: Rationale Statements for Selection of Compounds to be Tested in ILSI Alternatives to Carcinogenicity Testing Program.

Published in:: Toxicologic Pathology, 2001, v. 29, p. 323, doi. 10.1080/019262301753178645
Publication type:: Article

Clofibrate, a Peroxisome Proliferator–Activated Receptor-Alpha (PPARα) Agonist, and Its Molecular Mechanisms of Action against Sodium Fluoride–Induced Toxicity.

Published in:

Biological Trace Element Research, 2022, v. 200, n. 3, p. 1220, doi. 10.1007/s12011-021-02722-1

By:

Oyagbemi, Ademola Adetokunbo;
Adejumobi, Olumuyiwa Abiola;
Jarikre, Theophilus Aghogho;
Ajani, Olumide Samuel;
Asenuga, Ebunoluwa Racheal;
Gbadamosi, Idayat Titilayo;
Adedapo, Aduragbenro Deborah A.;
Aro, Abimbola Obemisola;
Ogunpolu, Blessing Seun;
Hassan, Fasilat Oluwakemi;
Falayi, Olufunke Olubunmi;
Ogunmiluyi, Iyanuoluwa Omolola;
Omobowale, Temidayo Olutayo;
Arojojoye, Oluwatosin Adetola;
Ola-Davies, Olufunke Eunice;
Saba, Adebowale Benard;
Adedapo, Adeolu Alex;
Emikpe, Benjamin Obukowho;
Oyeyemi, Matthew Olugbenga;
Nkadimeng, Sanah Malomile

Publication type:

Article

Clofibrate Treatment Decreases Inflammation and Reverses Myocardial Infarction-Induced Remodelation in a Rodent Experimental Model.

Published in:

Molecules, 2019, v. 24, n. 2, p. 270, doi. 10.3390/molecules24020270

By:

Ibarra-Lara, Luz;
Sánchez-Aguilar, María;
Soria-Castro, Elizabeth;
Vargas-Barrón, Jesús;
Roldán, Francisco J.;
Pavón, Natalia;
Torres-Narváez, Juan C.;
Cervantes-Pérez, Luz G.;
Pastelín-Hernández, Gustavo;
Sánchez-Mendoza, Alicia;
Capasso, Raffaele;
Iannotti, Fabio Arturo

Publication type:

Article

Ligand-induced expression of peroxisome proliferator-activated receptor α and activation of fatty acid oxidation enzymes in fatty liver.

Published in:

European Journal of Clinical Investigation, 2004, v. 34, n. 6, p. 429, doi. 10.1111/j.1365-2362.2004.01359.x

By:

Akbiyik, F.;
Cinar, K.;
Demirpence, E.;
Ozsullu, T.;
Tunca, R.;
Haziroglu, R.;
Yurdaydin, C.;
Uzunalimoglu, O.;
Bozkaya, H.

Publication type:

Article

The clofibrate saga: a retrospective commentary.

Published in:

British Journal of Clinical Pharmacology, 2012, v. 74, n. 6, p. 907, doi. 10.1111/j.1365-2125.2012.04282.x

By:

Oliver, Michael

Publication type:

Article

Four functional genotoxic marker genes (Bax, Btg2, Ccng1, and Cdkn1a) discriminate genotoxic hepatocarcinogens from non-genotoxic hepatocarcinogens and non-genotoxic non-hepatocarcinogens in rat public toxicogenomics data, Open TG-GATEs.

Published in:

Genes & Environment, 2024, v. 46, n. 1, p. 1, doi. 10.1186/s41021-024-00322-8

By:

Furihata, Chie;
Suzuki, Takayoshi

Publication type:

Article

Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.

Published in:

Current Medical Research & Opinion, 2007, v. 23, n. 5, p. 1147, doi. 10.1185/030079907X187982

By:

Iolo Doull;
David Price;
Mike Thomas;
Neil Hawkins;
Eugena Stamuli;
Maggie Tabberer;
Toby Gosden;
Helen Rudge

Publication type:

Article

Peroxisome proliferator-activated receptors (PPAR) downregulate the expression of pro-inflammatory molecules in an experimental model of myocardial infarction.

Published in:

Canadian Journal of Physiology & Pharmacology, 2016, v. 94, n. 6, p. 634, doi. 10.1139/cjpp-2015-0356

By:

Ibarra-Lara, María de la Luz;
Sánchez-Aguilar, María;
Soria, Elizabeth;
Torres-Narváez, Juan Carlos;
Del Valle-Mondragón, Leonardo;
Cervantes-Pérez, Luz Graciela;
Pérez-Severiano, Francisca;
Ramírez-Ortega, Margarita del Carmen;
Pastelín-Hernández, Gustavo;
Oidor-Chan, Víctor Hugo;
Sánchez-Mendoza, Alicia

Publication type:

Article

Assessment of Preclinical Liver and Skeletal Muscle Biomarkers Following Clofibrate Administration in Wistar Rats.

Published in:

Toxicologic Pathology, 2017, v. 45, n. 4, p. 506, doi. 10.1177/0192623317707271

By:

Maliver, Pierre;
Festag, Matthias;
Bennecke, Moritz;
Christen, Francois;
Bánfai, Balázs;
Lenz, Barbara;
Winter, Michael

Publication type:

Article